medline.ch Dermatologie Psoriasis

	The Role of TYK2 Inhibitors in the Pathogenesis and Treatment of Psoriasis. J Clin Aesthet Dermatol Burshtein J, Schlesinger T. PMID: 42761984 [PubMed]
	Evaluation of monocyte indices as predictors of adalimumab response in patients with psoriasis: A retrospective real-world data study. JAAD Int Krogh-Jensen O, Loft N, Kaur-Knudsen D, Zachariae C, Skov L, Kvist-Hansen A. PMID: 42761750 [PubMed]
	A diagnostic pitfall in psoriasiform lesions: From psoriasis to dermatomyositis. JAAD Case Rep Christopher PM, Mawu FO, Durry MF, Adji A. PMID: 42761532 [PubMed]
	Vunakizumab-induced severe ulcerative colitis during treatment of psoriatic arthritis: a case report and literature review. Front Immunol Cui Y, Tian J, Ma Z. PMID: 42761124 [PubMed - indexed for MEDLINE]
	Risk of psoriasis in patients treated with dupilumab for bullous pemphigoid: A cohort study. J Eur Acad Dermatol Venereol Curman P, Thapa M, Ludwig RJ, Kasperkiewicz M. PMID: 42760847 [PubMed - as supplied by publisher]
	Clinical and Biochemical Factors Associated With Hospitalization and Intensive Care Unit Admission Among Pregnant Women With Severe Psoriasis: A Retrospective Cohort Study. Cureus Abid H, Farooq ST, Uraneb S, Athif H, Akram MA, Shuja N. PMID: 42757122 [PubMed]
	Findings Interpretation Concerns Regarding the Emulated Target Trial of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Psoriatic Arthritis [Response to Letter]. Drug Des Devel Ther Yen FS, Wang SI, Hwu CM, Chen KY, Hsu CC, Wei JC. PMID: 42757044 [PubMed - in process]
	Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Psoriatic Arthritis: A DAPSA-Based Validation Study. Mediterr J Rheumatol Macía-Villa C, Ferre-Sanfrancisco M, Huerta-Tajuelo I, Morell-Hita JL. PMID: 42756319 [PubMed]
	Long-term comorbidities and mortality associations with treatment in generalized pustular psoriasis: a multi-institutional cohort study. Front Immunol Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. PMID: 42756109 [PubMed - indexed for MEDLINE]
	Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis). Dermatol Ther (Heidelb) Potestio L, Corrao S, Mastorino L, Gaiani FM, Cozzani EC, Maurelli M, Tommasino N, Caccavale S, Gargiulo L, Carrera CG, Sacchelli L, Longo C, Marchetti S, Michelucci A, Valguarnera D, Carugno A, Mozzato S, Lussana F, Mercadante L, Cangialosi L, Messina F, Di Brizzi EV, Bianco M, Scibetta S, Assorgi C, Campoli M, Angileri RG, Dattola A, Trovato E, Esposito M, Zerbinati N, Guarneri C, Loconsole F, Dini V, Campanati A, Lasagni C, Bardazzi F, Marzano AV, Travaglini M, Narcisi A, Balato A, Megna M, Girolomoni G, Burlando M, Malagoli P, Ribero S, Orsini D. PMID: 42754803 [PubMed - as supplied by publisher]
	Prevalence of depression among adult psoriatic patients in Palestine: a cross-sectional study in primary healthcare settings. BMJ Open Jawaadeh T, Ghayyada IA, Nazzal A, Alawneh M, Alshakhra K, Nazzal Z. PMID: 42754277 [PubMed - indexed for MEDLINE]
	Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort. Expert Opin Biol Ther Caso F, Celletti E, Pantano I, Mariani FM, Shariat Panahi A, Di Penta M, Ricciardi RM, Lo Gullo A, Mauro D, Saracino F, Ursini F, Costa L, Scarpa R, Giacomelli R, Ciccia F, Guggino G, Cipriani P, Ruscitti P. PMID: 42751974 [PubMed - as supplied by publisher]
	Early and Maintained Treat-to-Target Response with Ixekizumab up to 5 Years in Moderate-to-Severe Psoriasis: Analysis of the UNCOVER-3 Study. J Am Acad Dermatol Armstrong A, Merola JF, Chughtai R, Fotiou K, Ngantcha M, Sabatino S, Megna M, Man X, Honma M, Carrascosa JM, Pinter A. PMID: 42749063 [PubMed - as supplied by publisher]
	Optogenetic Dissection of Sensory Neuron-Macrophage Interactions in Psoriasiform Skin Inflammation: Advances Based on InÂ Vivo Calcium Imaging Techniques. Exp Dermatol Zheng P, Chen L. PMID: 42746671 [PubMed - indexed for MEDLINE]
	Secukinumab and Adalimumab on Bone Health in Psoriasis: A Longitudinal Cohort Study. Psoriasis (Auckl) Yu C, Zhao Z, Gao D, Fan J, Qiu Y, Zhang S, Wu N, Li C, Lyu H, Wang R. PMID: 42746600 [PubMed]
	Alcohol Use, Smoking, and Their Association with Early Onset and Severity of Psoriasis: a Case-Control Study. Addict Health Siddhan S, Johnson J, Ravishankar KS. PMID: 42746209 [PubMed]
	Type I interferon in psoriasis: mechanisms and clinical implications. Front Immunol Liu C, Zhang Y, Cui X, Zhang H, Chen J, Lian X, Yang S. PMID: 42746044 [PubMed - indexed for MEDLINE]
	Case Report: Near-complete resolution of nail psoriasis with upadacitinib in a pediatric patient. Front Immunol Huang Y, Wen S. PMID: 42745747 [PubMed - indexed for MEDLINE]
	Risks of tuberculosis, meningitis, candidiasis, and fungal infections among patients receiving systemic treatments for psoriasis: a nationwide cohort study from BADBIR data. Br J Dermatol Bright HRB, Smith CH, Laws P, Reynolds NJ, Phan DB, Lunt M, Warren RB, Yiu ZZN. PMID: 42740637 [PubMed - as supplied by publisher]
	Impact of Selective Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) on Molecular Pathways and Correlated Clinical Response in Patients With Active Psoriatic Arthritis. ACR Open Rheumatol Choudhury A, Cheng J, Tang J, Kumar S, Saha B, Arunachalam V, Hong T, Mark E, Wennbo H, McInnes IB. PMID: 42740479 [PubMed]

Artikel 1 - 20 / 28526

Seite 1 von 1427

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung